Shuangyi Cai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shuangyi Cai has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Ahmet Faruk Coskun
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA
4 shared publications - Mayar Allam
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, USA
3 shared publications Abhijeet Venkataraman
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, USA
1 shared publicationAdithya Pillai
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, USA
1 shared publication- Efe Ozturk
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, USA
1 shared publication - Eric V. Woods
Max Planck Institute for Sustainable Materials, Düsseldorf, Germany
1 shared publication
Latest Publications
- 30 October 2024
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 9 (7) , 1-23
Spatially resolved subcellular protein–protein interactomics in drug-perturbed lung-cancer cultures and tissues
Protein–protein interactions (PPIs) regulate signalling pathways and cell phenotypes, and the visualization of spatially resolved dynamics of PPIs would thus shed light on the activation and crosstalk of signalling networks. Here we report a method that leverages a sequential proximity ligation assay for the multiplexed profiling of PPIs with up to 47 proteins involved in multisignalling crosstalk pathways. We applied the method, followed by conventional immunofluorescence, to cell cultures and tissues of non-small-cell lung cancers with a mutated epidermal growth-factor receptor to determine the co-localization of PPIs in subcellular volumes and to reconstruct changes in the subcellular distributions of PPIs in response to perturbations by the tyrosine kinase inhibitor osimertinib. We also show that a graph convolutional network encoding spatially resolved PPIs can accurately predict the cell-treatment status of single cells. Multiplexed proximity ligation assays aided by graph-based deep learning can provide insights into the subcellular organization of PPIs towards the design of drugs for targeting the protein interactome.
- 30 October 2024
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 9 (7) , 1-23
Spatially resolved subcellular protein–protein interactomics in drug-perturbed lung-cancer cultures and tissues
Protein–protein interactions (PPIs) regulate signalling pathways and cell phenotypes, and the visualization of spatially resolved dynamics of PPIs would thus shed light on the activation and crosstalk of signalling networks. Here we report a method that leverages a sequential proximity ligation assay for the multiplexed profiling of PPIs with up to 47 proteins involved in multisignalling crosstalk pathways. We applied the method, followed by conventional immunofluorescence, to cell cultures and tissues of non-small-cell lung cancers with a mutated epidermal growth-factor receptor to determine the co-localization of PPIs in subcellular volumes and to reconstruct changes in the subcellular distributions of PPIs in response to perturbations by the tyrosine kinase inhibitor osimertinib. We also show that a graph convolutional network encoding spatially resolved PPIs can accurately predict the cell-treatment status of single cells. Multiplexed proximity ligation assays aided by graph-based deep learning can provide insights into the subcellular organization of PPIs towards the design of drugs for targeting the protein interactome.
- Open Access
- 29 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (5) , eabd0957
Spatially resolved 3D metabolomic profiling in tissues
Spatially resolved metabolic profiling and isotope-tagged protein analysis revealed unique lipid distributions in tissues.
- 29 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (5) , eabd0957
Open AccessSpatially resolved 3D metabolomic profiling in tissues
Spatially resolved metabolic profiling and isotope-tagged protein analysis revealed unique lipid distributions in tissues.
- 1 October 2020
- Published by Elsevier in Trends in Cancer
- Vol. 6 (10) , 813-818
Multiplex Spatial Bioimaging for Combination Therapy Design
- 1 October 2020
- Published by Elsevier in Trends in Cancer
- Vol. 6 (10) , 813-818
Multiplex Spatial Bioimaging for Combination Therapy Design
- Open Access
- 1 May 2020
- Published by Springer Nature in npj Precision Oncology
- Vol. 4 (1) , 1-14
Multiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
Cancers exhibit functional and structural diversity in distinct patients. In this mass, normal and malignant cells create tumor microenvironment that is heterogeneous among patients. A residue from primary tumors leaks into the bloodstream as cell clusters and single cells, providing clues about disease progression and therapeutic response. The complexity of these hierarchical microenvironments needs to be elucidated. Although tumors comprise ample cell types, the standard clinical technique is still the histology that is limited to a single marker. Multiplexed imaging technologies open new directions in pathology. Spatially resolved proteomic, genomic, and metabolic profiles of human cancers are now possible at the single-cell level. This perspective discusses spatial bioimaging methods to decipher the cascade of microenvironments in solid and liquid biopsies. A unique synthesis of top-down and bottom-up analysis methods is presented. Spatial multi-omics profiles can be tailored to precision oncology through artificial intelligence. Data-driven patient profiling enables personalized medicine and beyond.
- 1 May 2020
- Published by Springer Nature in npj Precision Oncology
- Vol. 4 (1) , 1-14
Open AccessMultiplex bioimaging of single-cell spatial profiles for precision cancer diagnostics and therapeutics
Cancers exhibit functional and structural diversity in distinct patients. In this mass, normal and malignant cells create tumor microenvironment that is heterogeneous among patients. A residue from primary tumors leaks into the bloodstream as cell clusters and single cells, providing clues about disease progression and therapeutic response. The complexity of these hierarchical microenvironments needs to be elucidated. Although tumors comprise ample cell types, the standard clinical technique is still the histology that is limited to a single marker. Multiplexed imaging technologies open new directions in pathology. Spatially resolved proteomic, genomic, and metabolic profiles of human cancers are now possible at the single-cell level. This perspective discusses spatial bioimaging methods to decipher the cascade of microenvironments in solid and liquid biopsies. A unique synthesis of top-down and bottom-up analysis methods is presented. Spatial multi-omics profiles can be tailored to precision oncology through artificial intelligence. Data-driven patient profiling enables personalized medicine and beyond.